Dr. Novack cited in New York Times article on safety of ophthalmic medications
Media Coverage, April 2024 — Dr. Novack was cited in a New York Times article discussing the safety of ophthalmic medications…
Unintended consequences of off-label use
The American Academy of Ophthalmology reported (June 2021) a shortage of bevacizumab as used off-label, aliquoted, for ophthalmic indications in the U.S. The issue surrounding off-label and compounding pharmacy use, particularly with this class of products, were discussed in a recent editorial by Dr. Novack…